Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study

Metabolism: Clinical and Experimental

Volumn 55, Issue 6, 2006, Pages 699-705

  Patel, Dharmendrakumar A ^a   Srinivasan, Sathanur R ^a   Xu, Ji Hua ^a   Li, Shengxu ^a   Chen, Wei ^a   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AFRICAN AMERICANS; BIOLOGICAL MARKERS; BODY WEIGHTS AND MEASURES; C-REACTIVE PROTEIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; SEX FACTORS;

EID: 33646503205     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.07.015     Document Type: Article

References (56)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
3. Tracy R.P., Lemaitre R.N., Psaty B.M., Ives D.G., Evans R.W., Cushman M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17 (1997) 1121-1127
4. Kuller L.H., Tracy R.P., Shaten J., and Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial. Am J Epidemiol 144 (1996) 537-547
5. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
6. Festa A., D'Agostino Jr. R., Howard G., Mykkänen L., Tracy R.P., and Haffner S.M. Chronic sub-clinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
7. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
8. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
9. Reaven G.M. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1998) 1595-1607
10. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
11. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., Lenfant C., American Heart Association, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
12. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
13. Ford E.S. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168 (2003) 351-358
14. Frohlich M., Imhof A., Berg G., Hutchinson W.L., Pepys M.B., Boeing H., et al. Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care 23 (2000) 1835-1839
15. Hak A.E., Stehouwer C.D., Bots M.L., Polderman K.H., Schalkwijk C.G., Westendrop I.C., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19 (1999) 1986-1991
16. Lemieux I., Pascot A., Prud'Homme D., et al. Elevated C-reactive protein, another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21 (2001) 961-967
17. The Bogalusa Heart Study 20th anniversary symposium. Am J Med Sci Suppl 1 (1995) S1-S138
18. Pouliot M.C., Despres J.P., Lemieux S., Moorjani S., Bouchard C., Tremblay A., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73 (1994) 460-468
19. Kahn H.S., Austin H., Williamson D.F., and Arensberg D. Simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol 49 (1996) 1017-1024
20. Sjöström L. A computer-tomography based multicompartment body composition technique and anthropometric predictors of lean body mass, total and subcutaneous adipose tissue. Int J Obes 15 (1991) 19-30
21. Srinivasan S.R., and Berenson G.S. Serum lipoproteins in children and methods for study. In: Lewis L.A. (Ed). Handbook of electrophoresis (1983), CRC Press, Boca Raton (FL) 185-204
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
23. Haffner S.M., Miettinen H., and Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 20 (1997) 1087-1092
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 285 (2001) 2486-2497
25. Jeppesen J., Facchini F.S., and Reaven G.M. Individuals with high total cholesterol/HDL cholesterol ratio are insulin resistant. J Intern Med 243 (1998) 293-298
26. Ford E.S., Giles W.H., Myers G.L., and Mannino D.M. Population distribution of high-sensitivity C-reactive protein among US men: findings from National Health and Nutrition Examination Survey 1999-2000. Clin Chem 49 (2003) 686-690
27. Ford E.S., Giles W.H., Mokdad A.H., and Myers G.L. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem 50 (2004) 574-581
28. Albert M.A., Glynn R.J., Buring J., and Ridker P.M. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93 (2004) 1238-1242
29. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312 (1996) 1061-1065
30. Ford E.S. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 108 (2003) 1053-1058
31. Laurell C.B., and Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens. J Clin Endocrinol Metab 49 (1979) 719-725
32. Jilka R.L., Hangoc G., Girasole G., Passeri G., Williams D.C., Abrams J.S., et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257 (1992) 88-91
33. Baumann H., and Gauldie J. The acute phase response. Immunol Today 15 (1994) 74-78
34. Tuck C.H., Holleran S., and Berglund L. Hormonal regulation of lipoprotein (a) levels: effects of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Vasc Biol 17 (1997) 1822-1829
35. Dreon D.M., Slvin J.L., and Phinney S.D. Oral contraceptive use and increased plasma concentration of C-reactive protein. Life Sci 73 (2003) 1245-1252
36. Kluft C., Leuven J.A., Helmerhost F.M., and Krans H.M. Proinflammatory effect of estrogens during use of oral contraceptives and hormone replacement treatment. Vascul Pharmacol 39 (2002) 149-154
37. Cushman M., Meilahn E.N., Psaty B.M., Kuller L.H., Dobs A.D., and Tracy R.P. Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler Thromb Vasc Biol 19 (1999) 893-899
38. Ridker P.M., Hennekens C.H., Rifai N., Buring J.E., and Manson J.E. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100 (1999) 713-716
39. Walsh B.W., Paul S., Wild R.A., Dean R.A., Tracy R.P., Cox D.A., et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 85 (2000) 214-218
40. Zamboni M., Turcato E., Armellini F., et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes Relat Metab Disord 22 (1998) 655-660
41. Janssen I., Katzmarzyk P.T., and Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79 (2004) 379-384
42. Pannacciulli N., Cantatore F.P., Minenna A., Bellacicco M., Giorgino R., and De Pergola G. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 25 (2001) 1416-1420
43. Tracy R.P. Is visceral adiposity the "enemy within"?. Arterioscler Thromb Vasc Biol 21 (2001) 881-883
44. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
45. McLaughlin T., Abbasi F., Lamendola C., Liang L., Reaven G., Schaaf P., et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106 (2002) 2908-2912
46. Wong N.D., Pio J., Valencia R., and Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol 4 (2001) 109-114
47. Olefsky J.M., Kolterman O.G., and Scarlett J.A. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 243 (1982) E15-E30
48. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J Clin Invest 106 (2000) 473-481
49. Srinivasan S.R., Myers L., and Berenson G.S. Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study. Metabolism 48 (1999) 928-934
50. Srinivasan S.R., Myers L., and Berenson G.S. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 51 (2002) 204-209
51. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
52. Pittas A.G., Joseph N.A., and Greenberg A.S. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89 (2004) 447-452
53. Mokdad A.H., Serdula M.K., Dietz W.H., Bowman B.A., Marks J.S., and Koplan J.P. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282 (1999) 1519-1522
54. Flegal K.M., Caroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
55. Heilbronn L.K., Noakes M., and Clifton P.M. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 21 (2001) 968-970
56. Geffken D.F., Cushman M., Burke G.L., Polak J.F., Sakkinen P.A., and Tracy R.P. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 153 (2001) 242-250